CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to revolutionize biopharmaceutical manufacturing by creating advanced purification technologies using nanofibers. These fibers will enhance the efficiency and sustainability of bio-drug production, making treatments more accessible to patients.
Biopharmaceutical drugs save lives and drastically improve well-being.
The number of new bio-drugs approved or in pipeline is rising but only 1/4 of patients have access to them.
Bioseparation is a critical step in biopharmaceuticals manufacture.
Bioseparation processes have low productivity, and are responsible for the environmental footprint and high cost of manufacturing.
They use polymeric adsorbents decorated with affinity ligands that increase the selective capture of the required bio-drug…
UNIVERSIDADE NOVA DE LISBOA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Bayreuth
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
